|
Search
Collections
Benchmarks
Upload document
Product
PBKR03
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
2 indications
Indication
leukodystrophy
Indication
Krabbe Disease
Clinical trial
A Phase 1/2 Open-Label, Multicenter Dose-Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of PBKR03 Administered to Pediatric Subjects With Early Infantile Krabbe Disease (Globoid Cell Leukodystrophy)
Status:
, Estimated PCD: 2027-01-01